Literature DB >> 11058558

Prostaglandin f(2alpha) induces distinct physiological responses in porcine corpora lutea after acquisition of luteolytic capacity.

F J Diaz1, T D Crenshaw, M C Wiltbank.   

Abstract

This study examines differences in intracellular responses to cloprostenol, a prostaglandin (PG)F(2alpha) analog, in porcine corpora lutea (CL) before (Day 9 of estrous cycle) and after (Day 17 of pseudopregnancy) acquisition of luteolytic capacity. Pigs on Day 9 or Day 17 were treated with saline or 500 microgram cloprostenol, and CL were collected 10 h (experiment I) or 0.5 h (experiment III) after treatment. Some CL were cut into small pieces and cultured to measure progesterone and PGF(2alpha) secretion. In experiment I, progesterone remained high and PGF(2alpha) low in luteal incubations from either Day 9 or Day 17 saline-treated pigs. Cloprostenol increased PGF(2alpha) production 465% and decreased progesterone production 87% only from Day 17 luteal tissue. Cloprostenol induced prostaglandin G/H synthase (PGHS)-2 mRNA (0.5 h) and protein (10 h) in both groups. In cell culture, cloprostenol or phorbol 12, 13-didecanoate (PDD) (protein kinase C activator), induced PGHS-2 mRNA in luteal cells from both groups. However, acute cloprostenol treatment (10 min) decreased progesterone production and increased PGF(2alpha) production only from Day 17 luteal cells. Thus, PGF(2alpha) production is induced by cloprostenol in porcine CL with luteolytic capacity (Day 17) but not in CL without luteolytic capacity (Day 9). However, this change in PGF(2alpha) production is not explained by a difference in induction of PGHS-2 mRNA or protein.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11058558     DOI: 10.1095/biolreprod63.5.1504

Source DB:  PubMed          Journal:  Biol Reprod        ISSN: 0006-3363            Impact factor:   4.285


  8 in total

1.  Patterns of gene expression in the bovine corpus luteum following repeated intrauterine infusions of low doses of prostaglandin F2alpha.

Authors:  Mehmet O Atli; Robb W Bender; Vatsal Mehta; Michele R Bastos; Wenxiang Luo; Chad M Vezina; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2012-04-27       Impact factor: 4.285

2.  Effect of decreasing intraluteal progesterone on sensitivity of the early porcine corpus luteum to the luteolytic actions of prostaglandin F2alpha.

Authors:  Francisco J Diaz; Wenxiang Luo; Milo C Wiltbank
Journal:  Biol Reprod       Date:  2010-08-25       Impact factor: 4.285

3.  Induction of mRNA for chemokines and chemokine receptors by prostaglandin F2α is dependent upon stage of the porcine corpus luteum and intraluteal progesterone.

Authors:  Wenxiang Luo; Francisco J Diaz; Milo C Wiltbank
Journal:  Endocrinology       Date:  2011-04-19       Impact factor: 4.736

4.  Heat stress during the luteal phase decreases luteal size but does not affect circulating progesterone in gilts1.

Authors:  Katie L Bidne; Matthew R Romoser; Jason W Ross; Lance H Baumgard; Aileen F Keating
Journal:  J Anim Sci       Date:  2019-10-03       Impact factor: 3.159

5.  Prostaglandin F2α regulation of mRNA for activating protein 1 transcriptional factors in porcine corpora lutea (CL): lack of induction of JUN and JUND in CL without luteolytic capacity.

Authors:  F J Diaz; W Luo; M C Wiltbank
Journal:  Domest Anim Endocrinol       Date:  2012-10-08       Impact factor: 2.290

6.  Estradiol-17β Regulates Expression of Luteal DNA Methyltransferases and Genes Involved in the Porcine Corpus Luteum Function In Vivo.

Authors:  Piotr Kaczynski; Monika Baryla; Ewelina Goryszewska; Agnieszka Waclawik
Journal:  Int J Mol Sci       Date:  2021-04-01       Impact factor: 5.923

Review 7.  Luteinizing Hormone Regulation of Inter-Organelle Communication and Fate of the Corpus Luteum.

Authors:  Emilia Przygrodzka; Michele R Plewes; John S Davis
Journal:  Int J Mol Sci       Date:  2021-09-15       Impact factor: 6.208

Review 8.  Regulation of intraluteal production of prostaglandins.

Authors:  Milo C Wiltbank; Joseph S Ottobre
Journal:  Reprod Biol Endocrinol       Date:  2003-11-10       Impact factor: 5.211

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.